Prescient Therapeutics Limited (ASX:PTX)

Prescient Therapeutics Revenue

Prescient Therapeutics had revenue of 1.25M AUD in the half year ending December 31, 2024, a decrease of -0.49%. This brings the company's revenue in the last twelve months to 3.02M, down -2.97% year-over-year. In the fiscal year ending June 30, 2024, Prescient Therapeutics had annual revenue of 3.71M with 52.89% growth.

• Revenue (ttm): 3.02M
• Revenue Growth: -2.97%
• P/S Ratio: 12.53
• Revenue / Employee: 1.01M
• Employees: 3
• Market Cap: 37.85M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	3.71M	1.28M	52.89%
Jun 30, 2023	2.43M	538.79K	28.52%
Jun 30, 2022	1.89M	703.86K	59.37%
Jun 30, 2021	1.19M	156.14K	15.17%
Jun 30, 2020	1.03M	-618.42K	-37.53%